Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8428899rdf:typepubmed:Citationlld:pubmed
pubmed-article:8428899lifeskim:mentionsumls-concept:C0001492lld:lifeskim
pubmed-article:8428899lifeskim:mentionsumls-concept:C0597298lld:lifeskim
pubmed-article:8428899lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:8428899lifeskim:mentionsumls-concept:C0079411lld:lifeskim
pubmed-article:8428899lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:8428899pubmed:issue4lld:pubmed
pubmed-article:8428899pubmed:dateCreated1993-3-8lld:pubmed
pubmed-article:8428899pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8428899pubmed:abstractTextA truncated form of adenylylcyclase (type V-alpha) has been cloned from a cardiac cDNA library. It constitutes a half-molecule of type V adenylylcyclase diverging at the end of the first cytoplasmic loop. Northern blotting study has revealed the presence of such a mRNA species (approximately 3.5 kilobases in size) in the heart. Genomic sequence analysis has revealed that type V-alpha is generated via usage of a polyadenylation signal located within an intronic sequence of type V adenylylcyclase gene. When type V-alpha is co-expressed with an artificially generated half-molecule constituting the latter half of type V adenylylcyclase, the catalytic activity in transfected cell membranes is significantly higher than that of controls. However, when either alone is overexpressed, no significant increase in catalytic activity results. These results indicate that a half-molecule of adenylylcyclase, i.e. a protein containing six-transmembrane spans followed by a single cytoplasmic domain, can be generated in vivo, but catalytic activity is lacking unless heterodimerization can occur. This finding identifies another potential mechanism for generating diversity within this enzyme family.lld:pubmed
pubmed-article:8428899pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8428899pubmed:languageenglld:pubmed
pubmed-article:8428899pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8428899pubmed:citationSubsetIMlld:pubmed
pubmed-article:8428899pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8428899pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8428899pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8428899pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8428899pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8428899pubmed:statusMEDLINElld:pubmed
pubmed-article:8428899pubmed:monthFeblld:pubmed
pubmed-article:8428899pubmed:issn0021-9258lld:pubmed
pubmed-article:8428899pubmed:authorpubmed-author:IshikawaYYlld:pubmed
pubmed-article:8428899pubmed:authorpubmed-author:HomcyC JCJlld:pubmed
pubmed-article:8428899pubmed:authorpubmed-author:KatsushikaSSlld:pubmed
pubmed-article:8428899pubmed:authorpubmed-author:KawabeJJlld:pubmed
pubmed-article:8428899pubmed:issnTypePrintlld:pubmed
pubmed-article:8428899pubmed:day5lld:pubmed
pubmed-article:8428899pubmed:volume268lld:pubmed
pubmed-article:8428899pubmed:ownerNLMlld:pubmed
pubmed-article:8428899pubmed:authorsCompleteYlld:pubmed
pubmed-article:8428899pubmed:pagination2273-6lld:pubmed
pubmed-article:8428899pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:8428899pubmed:meshHeadingpubmed-meshheading:8428899-...lld:pubmed
pubmed-article:8428899pubmed:meshHeadingpubmed-meshheading:8428899-...lld:pubmed
pubmed-article:8428899pubmed:meshHeadingpubmed-meshheading:8428899-...lld:pubmed
pubmed-article:8428899pubmed:meshHeadingpubmed-meshheading:8428899-...lld:pubmed
pubmed-article:8428899pubmed:meshHeadingpubmed-meshheading:8428899-...lld:pubmed
pubmed-article:8428899pubmed:meshHeadingpubmed-meshheading:8428899-...lld:pubmed
pubmed-article:8428899pubmed:meshHeadingpubmed-meshheading:8428899-...lld:pubmed
pubmed-article:8428899pubmed:meshHeadingpubmed-meshheading:8428899-...lld:pubmed
pubmed-article:8428899pubmed:meshHeadingpubmed-meshheading:8428899-...lld:pubmed
pubmed-article:8428899pubmed:meshHeadingpubmed-meshheading:8428899-...lld:pubmed
pubmed-article:8428899pubmed:meshHeadingpubmed-meshheading:8428899-...lld:pubmed
pubmed-article:8428899pubmed:meshHeadingpubmed-meshheading:8428899-...lld:pubmed
pubmed-article:8428899pubmed:meshHeadingpubmed-meshheading:8428899-...lld:pubmed
pubmed-article:8428899pubmed:meshHeadingpubmed-meshheading:8428899-...lld:pubmed
pubmed-article:8428899pubmed:meshHeadingpubmed-meshheading:8428899-...lld:pubmed
pubmed-article:8428899pubmed:meshHeadingpubmed-meshheading:8428899-...lld:pubmed
pubmed-article:8428899pubmed:year1993lld:pubmed
pubmed-article:8428899pubmed:articleTitleIn vivo generation of an adenylylcyclase isoform with a half-molecule motif.lld:pubmed
pubmed-article:8428899pubmed:affiliationDepartment of Pharmacology, College of Physicians and Surgeons, Columbia University, New York, New York 10032.lld:pubmed
pubmed-article:8428899pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8428899pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8428899pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:403859entrezgene:pubmedpubmed-article:8428899lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8428899lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8428899lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8428899lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8428899lld:pubmed